The study determined that the risk of NAION vision loss was 6.7% in patients who took semaglutide vs 0.89% in patients who took other antidiabetic medications
The current clinical evidence of intravenous glutathione for skin lightening is limited to a single study with a dubious study design and apparently flawed analysis of results, casting doubt on the drug's efficacy and reported adverse effects, with no evidence to prove its efficacy.There was only one placebo-controlled study on intravenous glutathione showing 37.5% response versus 18.7% placebo, and IV glutathione is contraindicated due to lack of efficacy and side effects
Pharmaceutical GLP-1 receptor agonists have become popular for their effectiveness in improving metabolic health
Glutathione is frequently called the "master antioxidant." It is a tripeptide, which simply means it is made of three amino acids: cysteine, glycine, and glutamic acid
Only one form, -tocopherol, meets human vitamin E requirements (see The RDA)
Semaglutide has been prescribed as an effective weight-loss medicine, providing long-term benefits with sustained use